These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 7683960)

  • 21. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
    Watanabe Y; Kato H; Araki T
    Metab Brain Dis; 2008 Mar; 23(1):51-69. PubMed ID: 18030609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions among deprenyl, clorgyline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on catecholamines in mice.
    Lee EH; Yang YL; Chia LG; Kuo JS
    Neurosci Lett; 1994 Jan; 165(1-2):149-52. PubMed ID: 7912414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.
    Mackenzie GM; Jackson MJ; Jenner P; Marsden CD
    Synapse; 1997 Jul; 26(3):301-16. PubMed ID: 9183819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.
    Yano R; Yokoyama H; Kuroiwa H; Kato H; Araki T
    J Mol Neurosci; 2009 Sep; 39(1-2):211-9. PubMed ID: 19199078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP.
    Seniuk NA; Tatton WG; Greenwood CE
    Brain Res; 1990 Sep; 527(1):7-20. PubMed ID: 1980841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity.
    Kita T; Saraya T; Konishi N; Matsunari Y; Shimada K; Nakamura M; O'Hara K; Wagner GC; Nakashima T
    Pharmacol Toxicol; 2003 Feb; 92(2):71-80. PubMed ID: 12747576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.
    Rommelfanger KS; Edwards GL; Freeman KG; Liles LC; Miller GW; Weinshenker D
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13804-9. PubMed ID: 17702867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D; Unsicker K
    J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
    Yokoyama H; Takagi S; Watanabe Y; Kato H; Araki T
    J Neural Transm (Vienna); 2008 Jun; 115(6):831-42. PubMed ID: 18235988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
    Date I; Felten DL; Felten SY
    Brain Res; 1990 Jun; 519(1-2):266-76. PubMed ID: 1975765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration.
    Mao L; Lau YS; Petroske E; Wang JQ
    Brain Res Dev Brain Res; 2001 Nov; 131(1-2):57-65. PubMed ID: 11718836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity.
    Choi JY; Jang EH; Park CS; Kang JH
    Free Radic Biol Med; 2005 Mar; 38(6):806-16. PubMed ID: 15721991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor-κB reporter mice prior to loss of dopaminergic neurons.
    Miller JA; Trout BR; Sullivan KA; Bialecki RA; Roberts RA; Tjalkens RB
    J Neurosci Res; 2011 Mar; 89(3):406-17. PubMed ID: 21259327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
    Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.